The cost-effectiveness of tiotropium for the treatment of chronic obstructive pulmonary disease (COPD): the importance of the comparator

被引：0
作者：
Mattias Neyt
Ann Van Den Bruel
机构：
[1] Belgian Health Care Knowledge Centre (KCE),Department of Primary Care Health Sciences
[2] University of Oxford,undefined
来源：
The European Journal of Health Economics | 2012年 / 13卷
关键词：
Chronic Obstructive Pulmonary Disease; Salmeterol; Health Technology Assessment; Formoterol; Tiotropium;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：379 / 380
页数：1
相关论文
共 21 条
[1]  
Zaniolo O(2012)Pharmacoeconomic evaluation of tiotropium bromide in the long-term treatment of chronic obstructive pulmonary disease (COPD) in Italy Eur J Health Econ 13 71-80
[2]  
Iannazzo S(2011)The importance of the comparator in economic evaluations: working on the efficiency frontier PharmacoEconomics 29 913-916
[3]  
Pradelli L(2010)Does tiotropium lower exacerbation and hospitalization frequency in COPD patients: results of a meta-analysis BMC Pulm Med 10 50-404
[4]  
Miravitlles M(2003)Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD Thorax 58 399-404
[5]  
Neyt M(2005)Improved daytime spirometric efficacy of tiotropium compared with salmeterol in patients with COPD Pulm. Pharmacol. Ther. 18 397-undefined
[6]  
Van Brabandt H(undefined)undefined undefined undefined undefined-undefined
[7]  
Van den Bruel A(undefined)undefined undefined undefined undefined-undefined
[8]  
Gailly J(undefined)undefined undefined undefined undefined-undefined
[9]  
Neyt M(undefined)undefined undefined undefined undefined-undefined
[10]  
Brusasco V(undefined)undefined undefined undefined undefined-undefined
123